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Introduction: Myocardial sarcoidosis is known as a significant complication of sarcoidosis, but Holter
electrocardiographic monitoring or echocardiograms might not be sensitive enough to detect cardiac involvement.
While gallium scintigraphy has been recommended, 18F-fluorodeoxyglucose positron emission tomography-computed
tomography might be more sensitive to detect sarcoidosis.
Case presentations: This report comprises the cases of 12 Japanese patients. Two were male, and ten were female.
Their age range was between 32 and 93 years. The average age of the patients was 63. We found internal involvement
of sarcoidosis in eight (89%) of nine patients by positron emission tomography-computed tomography and in two (67%)
of three patients by gallium scintigraphy. Myocardial sarcoidosis was detected in four (33%) of twelve patients, and
specifically in three (75%) of four facial multiple plaque type sarcoidosis patients.
Conclusion: The myocardial lesions detected by positron emission tomography-computed tomography could not be
detected with conventional electrocardiogram or echogram. Positron emission tomography-computed tomography can
detect sarcoid lesions of the whole body and is useful for the follow up of patients. We recommend positron emission
tomography-computed tomography for those patients having cutaneous sarcoidosis, especially facial multiple plaque
type sarcoidosis.
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Sarcoidosis is a systemic granulomatous disease with in-
volvement of various organs [1]. The various types of cu-
taneous sarcoidosis have been described previously, but
the relation between cutaneous sarcoidosis and severity
of general sarcoidosis has been shrouded in mystery [2].
Myocardial sarcoidosis is known as a significant com-
plication, but Holter electrocardiographic monitoring
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reproduction in any medium, provided the ordetect cardiac involvement [3]. Although gallium (67Ga)
scintigraphy has been recommended as a diagnostic tool,
18F-fluorodeoxyglucose positron emission tomography-
computed tomography (PET-CT) imaging might be
more sensitive in detecting sarcoidosis [4]. Previous re-
ports have suggested no significant difference between
Ga scintigraphy and PET-CT [5]. Because myocardial
sarcoidosis may result in unexpected sudden death [6],
cardiac abnormalities should be adequately evaluated
early in the course of the disease.
In this report, we investigated the relationship of cuta-
neous sarcoidosis and internal involvement, including
myocardial sarcoidosis, using PET-CT and Ga scintig-
raphy. Among 12 patients, we found that 10 patients
(83%) had internal involvement (Table 1). To the best ofral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Patient demographics, affected areas, clinical types of sarcoidosis and complications
Patient Sex Age
(years)




Other positive regions Complications
1 M 66 Plaque (face) PET + Mediastinal LN diaphragm left
parotid gland
Sjögren syndrome
2 F 74 Plaque (face) PET + Mediastinal LN Hepatitis C virus




4 F 48 Plaque (face) PET + Mediastinal LN retroperitoneal
LN Periaortal LN neck LN
Past history of lung
tuberculosis Hepatitis B
virus






6 F 59 Nodule (face) PET – Mediastinal LN –
7 F 68 Nodule (face) PET – Mediastinal LN right leg skin Antinuclear antigen–
positive (×1280)
8 F 58 Nodule (face) Ga
Scintigraphy
– Mediastinal LN Hashimoto's disease
9 F 32 Nodule (face, right knee) PET – – –




11 F 43 Scar (both knees) PET – Mediastinal LN Myoma uteri
12 M 73 Subcutaneous type (face) nodule
(left arm), papules (entire body)
Ga
Scintigraphy
– – Past history of lung
tuberculosis Hepatitis C
virus
Ga, gallium; LN, lymph node; PET, positron emission tomography.
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PET-CT is useful for detecting internal involvement in
the cutaneous multiple plaque type of sarcoidosis.
Case presentations
Patient 1
A 66-year-old Japanese man with asymptomatic facial pla-
ques of 6 months’ duration presented to our institution. He
had no fever or arthralgia. Physical examination revealed
up to 12mm oval erythematous plaques on his face
(Figure 1A). His complete blood count, liver function
tests and serum electrolytes were all normal. The anti-
deoxyribonucleic acid (DNA) antibody and antinuclear
antibody (ANA) were negative, but the anti-SSA antibody
was positive. His serum immunoglobulin G was elevated to
2026mg/dl (normal, 870mg/dl to 1700mg/dl). His serum
angiotensin-converting enzyme (ACE) level was normal
(13.0IU/L; normal, 7.7IU/L to 29.4IU/L), but his serum
lysozyme level was slightly elevated (11.5g/ml; normal,
4g/ml to 11g/ml). Histopathologically, naked epithelioid cell
granulomas with giant cells were observed in the upper
dermis (Figure 1B). Ophthalmologically, goniosynechia and
retinal and choroid exudates were observed. Schirmer’s test
was negative. Lip biopsy findings were consistent with
Sjögren syndrome with lymphoid cell infiltration aroundthe salivary gland. We diagnosed the patient with facial
plaque type cutaneous sarcoidosis with Sjögren syndrome.
PET-CT images revealed mediastinal and hilar LN swelling
(Figure 1C), as well as involvement of the myocardium
(Figure 1D), diaphragm (Figure 1E) and left parotid gland
(Figure 1F). Cardiac echocardiographic and Holter electro-
cardiographic images did not show any abnormalities. A
cardiovascular physician conducted follow-up of the patient
for his cardiac involvement.
Patient 2
A 74-year-old Japanese woman had asymptomatic pla-
ques of 3 months’ duration. She had had hepatitis C
virus for about 5 years. No palpitations, syncope history
or arrhythmias were detected. Her physical examination
revealed 5mm, irregularly shaped plaques on her face
(Figure 2A). She had never received interferon therapy.
Her complete blood count, liver function tests and
serum electrolytes were all normal. ACE, lysozyme and
ANA levels were also normal. Histopathologically, naked
epithelial cell granuloma with giant cells were observed
in the upper dermis (Figure 2B). PET-CT images re-
vealed mediastinal and hilar lymph node (LN) swelling
and multiple middle and inferior myocardial wall up-
takes (Figure 2C). Her cardiac ejection fraction rate was
Figure 1 Clinical appearance of patient 1. (A) Up to 12 mm oval erythematous plaques on the patient’s face are shown. (B) Histopathological
findings of patient 1 (hematoxylin and eosin stain, original magnification, ×100). Naked epithelioid cell granulomas accompanied by giant cells
were observed in the upper dermis. (C) Positron emission tomography image of patient 1. Mediastinal and hilar lymph nodes show positive
results. (D) Cardiac apex shows accumulation of 18F-fluorodeoxyglucose. (E) A positive result in the diaphragm is shown. (F) The left parotid
gland was also positive.
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ventricular contractions and right bundle branch block.
She was treated with 30mg prednisolone, and a pace-
maker was implanted by a cardiovascular physician.Other patients’ symptoms
The other 12 patients were also Japanese. Two were
male, and ten were female. Their ages ranged from 32 to
93 years. Their average age was 63 (Table 1). Among the
Figure 2 Clinical appearance of patient 2. (A) Five-millimeter,
irregularly shaped plaques are shown. (B) Histopathological findings
of patient 2 (hematoxylin and eosin stain; original magnification ×
100). Naked epithelioid cell granuloma with giant cells can be seen
in the upper dermis. (C) Positron emission tomography image of
patient 2. Multiple myocardial focal uptakes are observed at the
middle to inferior wall. HLA means horizontal long axis, VLA means
vertical long axis, and SA means short axis in Figure 2-C.
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volvement. Internal involvement was found in eight (89%)
of nine patients by PET-CT and in two (67%) of three by
Ga scintigraphy. Cardiac involvement was found in four
(33%) of the twelve patients. In the 12 patients, we found
a predominance of myocardial sarcoidosis with multiple
facial plaque type cutaneous sarcoidosis (75%) without
subjective symptoms. Autoimmune-associated disease wasfound in four patients, and viral hepatitis was detected in
three. In our series, two patients (17%) had a history of
Mycobacterium infections with positive tuberculin tests
and QuantiFERON® TB2G tests (Cellestis, Chadstone,
Australia). We used special stains, including, Bacille
Calmette-Guérin stain, Grocott’s methenamine silver stain,
periodic acid–Schiff stain or Ziehl–Neelsen stain, to visua-
lize acid-fast bacteria, but we could not find acid-fast bac-
teria, fungus or bacterial cutaneous infection in any of the
biopsy samples. Cutaneous sarcoidosis was diagnosed on
the basis of histopathology by the pathologist.Discussion
Sarcoidosis is a multisystem granulomatous disease of un-
known etiology [1]. We performed screening for internal
involvement by PET-CT and Ga scintigraphy in 12 cutane-
ous sarcoidosis patients. The results showed the usefulness
of PET-CT for detection of internal involvement, especially
for myocardial sarcoidosis. Our patients who had myocar-
dial sarcoidosis did not show any subjective symptoms or
any remarkable changes at the time the first electrocardio-
gram was taken. Because myocardial sarcoidosis may cause
unexpected sudden death [6], cardiac abnormalities should
be evaluated appropriately early in the course of the disease
[4]. Although cardiac magnetic resonance imaging with
gadolinium enhancement may be another approach, it de-
tects only heart lesions [1-4]. PET-CT scans can allow clini-
cians to detect sarcoid lesions of the whole body and are
useful for the follow-up of patients who receive pacemakers
[1-4].
The various types of cutaneous sarcoidosis have been
described previously, but the relation between cutaneous
sarcoidosis and the severity of general sarcoidosis has
been shrouded in mystery [2]. Our patient examinations
revealed that myocardial sarcoidosis was more prevalent
in patients with the multiple facial plaque type of cuta-
neous sarcoidosis (Table 1). On the one hand, the sever-
ity of myocardial sarcoidosis did not correlate with
cutaneous sarcoidosis involvement (compare Figure 1A
with Figure 2A). On the other hand, four patients had
various multiple internal and LN involvements that were
detected by PET-CT (Table 1), and three of these four
patients also had myocardial sarcoidosis (75%). This pat-
tern suggests that multiple lesions detected by PET-CT
might be associated with myocardial sarcoidosis.
Sarcoidosis is accompanied by many complications,
which include various autoimmune diseases that may
cause lymphadenopathy [7,8]. Our patients had Sjögren
syndrome, rheumatoid arthritis, Hashimoto disease and
positive ANAs (×1280). This may be related to the
immunopathogenic mechanism of sarcoidosis, which in-
cludes T-helper type 1 cell–related, uncontrolled, cell-
mediated immunity.
Nakamura et al. Journal of Medical Case Reports 2014, 8:17 Page 5 of 5
http://www.jmedicalcasereports.com/content/8/1/17A recent report showed the relation of sarcoidosis to
hepatitis C viral infection [9]. One is triggered by antiviral
therapies (75%), but the other is unrelated to the treatment
(25%) [9]. The myocardial sarcoidosis was also associated
with viral hepatitis in three cases (67%) without treatment
by interferon. The significance of the relation of myocardial
sarcoidosis and viral hepatitis remains to be determined.
Mycobacterium and Propionibacterium have been identified
as causative antigens of sarcoidosis [10]. The higher ratio of
history of tuberculosis (17% vs. 9.2% of the same-age con-
trols in 2009) might suggest the relationship between tuber-
culosis and sarcoidosis. In another report, Tchernev et al.
suggested that the autoimmune etiology of sarcoidosis
might occur through a process of molecular mimicry
of infectious or other environmental antigens to host
antigens [2].
Conclusion
PET-CT can be used to detect sarcoid lesions of the whole
body and is useful in patient follow-up. PET-CT has been
shown to be quite useful for the detection of myocardial
sarcoidosis, which was highly associated with the multiple
facial plaque type of sarcoidosis. Although other associated
involvements were noted in our patients, the significance in
terms of the development of clinical sarcoidosis remains to
be determined.
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